Good Start Genetics, Inc. said it has appointed Charles F. Wagner, Jr. to its board of directors.
Wagner is currently chief financial officer and executive vice president, finance and administration of Bruker Corp. (NASDAQ: BRKR). He holds a B.S. from Boston College and an MBA from Harvard University Graduate School of Business Administration.
GoodStart Select is Good Start Genetics´ menu of genetic carrier screening tests that, for diseases such as cystic fibrosis, detects many more disease-causing mutations than traditional genotyping-based screening tests, regardless of patient ethnicity.
To support its genetic carrier screening capabilities, Good Start Genetics has a dedicated team of customer care specialists and board certified genetic counselors who provide step-by-step support, from test selection through results, analysis and reporting. Good Start Genetics seeks to enable reproductive health specialists and their patients to have the highest degree of confidence in their genetic carrier screening results.
Good Start Genetics is a commercial-stage molecular genetic information company focused on fundamentally transforming the standard of care in reproductive medicine by providing physicians and their patients with clinically relevant and actionable information concerning inherited genetic disorders. For more information, visit www.goodstartgenetics.com.